Insulin
Insulin is produced by the beta cells of the islets of Langerhans in the pancreas. It consists of an A-chain of 21 amino acids and a B-chain of 30 aminoacids. Pro-insulin, the precursor of insulin, is a single polypeptide chain 1.5 times the size of insulin. It is cleaved into insulin and C-peptide which are therefore secreted in equimolar amounts. C-peptide levels reflect endogenous insulin secretion and are widely used for research purposes. About 3-5% of pro-insulin escapes the cleavage process and is secreted intact.
There are various types of insulin preparation used in the treatment of diabetes mellitus:
- very rapidly-acting insulin e.g. insulin lispro or insulin aspart
- short-acting e.g. human actrapid
- intermediate-acting insulin e.g. human insulatard
- long-acting-acting insulin
- mixtures containing specific proportions of short and intermediate-acting insulins
Commercial insulin is generally recombinant human insulin; although animal insulins are still available.
Notes:
- long-acting human insulin analogue are an alternative to intermediate-acting insulin
Related pages
- Preparations
- Pancreatic beta cell physiology
- Functions
- Indications for insulin
- Complications of insulin therapy
- Initial doses of insulin in the newly diagnosed diabetic
- Insulin regimens in insulin-dependent diabetes mellitus
- NICE guidance - the use of long-acting insulin analogues for the treatment of type 2 diabetes - insulin glargine and insulin detemir
- Insulin regimes in Type 2 diabetes
- Insulin - human to analogue transfer
- Discontinuation of Levemir (insulin detemir) and switching strategies
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.